{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:02:45Z","timestamp":1757628165047,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91947","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:52:17Z","timestamp":1757483537000},"source":"Crossref","is-referenced-by-count":0,"title":["A Clinical and Risk Factor Profile of Patients With Tubo-Ovarian Abscesses: A Retrospective Study From Two District Hospitals in the United Kingdom"],"prefix":"10.7759","author":[{"given":"Rupa","family":"Brahma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwesha","family":"Dasghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2008.05.008","article-title":"Pelvic inflammatory disease and tubo-ovarian abscess","volume":"22","author":"Lareau SM","year":"2008","unstructured":"Lareau SM, Beigi RH. Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am. 2008, 22:693-708. 10.1016\/j.idc.2008.05.008","journal-title":"Infect Dis Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2009.01.010","article-title":"The management of pelvic abscess","volume":"23","author":"Granberg S","year":"2009","unstructured":"Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009, 23:667-78. 10.1016\/j.bpobgyn.2009.01.010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12447","article-title":"Diagnosis and management of tubo-ovarian abscesses","volume":"20","author":"Munro K","year":"2018","unstructured":"Munro K, Gharaibeh A, Nagabushanam S, Martin C. Diagnosis and management of tubo-ovarian abscesses. Obstet Gynaecol. 2018, 20:11-9. 10.1111\/tog.12447","journal-title":"Obstet Gynaecol"},{"key":"ref4","article-title":"Pelvic inflammatory disease: diagnosis and treatment in the emergency department [digest]","volume":"18","author":"Bugg CW","year":"2016","unstructured":"Bugg CW, Taira T, Zaurova M. Pelvic inflammatory disease: diagnosis and treatment in the emergency department [digest]. Emerg Med Pract. 2016, 18:S1-2.","journal-title":"Emerg Med Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2020.09.014","article-title":"Outcomes of minimally invasive management of tubo-ovarian abscess: a systematic review","volume":"28","author":"Goje O","year":"2021","unstructured":"Goje O, Markwei M, Kollikonda S, Chavan M, Soper DE. Outcomes of minimally invasive management of tubo-ovarian abscess: a systematic review. J Minim Invasive Gynecol. 2021, 28:556-64. 10.1016\/j.jmig.2020.09.014","journal-title":"J Minim Invasive Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4161394","article-title":"Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population","volume":"2019","author":"Chan GM","year":"2019","unstructured":"Chan GM, Fong YF, Ng KL. Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population. Infect Dis Obstet Gynecol. 2019, 2019:4161394. 10.1155\/2019\/4161394","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2019.04.027","article-title":"Can the need for invasive intervention in tubo-ovarian abscess be predicted? The implication of C-reactive protein measurements","volume":"27","author":"Ribak R","year":"2020","unstructured":"Ribak R, Schonman R, Sharvit M, Schreiber H, Raviv O, Klein Z. Can the need for invasive intervention in tubo-ovarian abscess be predicted? The implication of C-reactive protein measurements. J Minim Invasive Gynecol. 2020, 27:541-7. 10.1016\/j.jmig.2019.04.027","journal-title":"J Minim Invasive Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/847041","article-title":"Tuboovarian abscesses: is size associated with duration of hospitalization & complications?","volume":"2010","author":"Dewitt J","year":"2010","unstructured":"Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications?. Obstet Gynecol Int. 2010, 2010:847041. 10.1155\/2010\/847041","journal-title":"Obstet Gynecol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000072076","article-title":"Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment?","volume":"55","author":"Halperin R","year":"2003","unstructured":"Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D. Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment?. Gynecol Obstet Invest. 2003, 55:211-5. 10.1159\/000072076","journal-title":"Gynecol Obstet Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu MS","year":"2017","unstructured":"Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017, 13:851-63. 10.5114\/aoms.2016.58928","journal-title":"Arch Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000533244.87701.b8","article-title":"Impact of BMI on pelvic inflammatory disease [32Q]","volume":"131","author":"Ashrafian S","year":"2018","unstructured":"Ashrafian S, Uyar D. Impact of BMI on pelvic inflammatory disease [32Q]. Obstetrics & Gynecology. 2018, 131:192-3. 10.1097\/01.AOG.0000533244.87701.b8","journal-title":"Obstetrics & Gynecology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2018.06.013","article-title":"Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score","volume":"26","author":"Fouks Y","year":"2019","unstructured":"Fouks Y, Cohen A, Shapira U, Solomon N, Almog B, Levin I. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. J Minim Invasive Gynecol. 2019, 26:535-43. 10.1016\/j.jmig.2018.06.013","journal-title":"J Minim Invasive Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)91436-z","article-title":"Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens","volume":"164","author":"Reed SD","year":"1991","unstructured":"Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol. 1991, 164:1556-61. 10.1016\/0002-9378(91)91436-z","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e92c54","article-title":"Pelvic inflammatory disease","volume":"116","author":"Soper DE","year":"2010","unstructured":"Soper DE. Pelvic inflammatory disease. Obstet Gynecol. 2010, 116:419-28. 10.1097\/AOG.0b013e3181e92c54","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2022.04.026","article-title":"High risk and low prevalence diseases: tubo-ovarian abscess","volume":"57","author":"Bridwell RE","year":"2022","unstructured":"Bridwell RE, Koyfman A, Long B. High risk and low prevalence diseases: tubo-ovarian abscess. Am J Emerg Med. 2022, 57:70-5. 10.1016\/j.ajem.2022.04.026","journal-title":"Am J Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.01.011","article-title":"Can antibiotic treatment failure in tubo-ovarian abscess be predictable?","volume":"258","author":"Akselim B","year":"2021","unstructured":"Akselim B, Kara\u015fin SS, Demirci A, \u00dcst\u00fcnyurt E. Can antibiotic treatment failure in tubo-ovarian abscess be predictable?. Eur J Obstet Gynecol Reprod Biol. 2021, 258:253-7. 10.1016\/j.ejogrb.2021.01.011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70100","article-title":"The tubo-ovarian abscess study (TOAST): a single-center retrospective review of predictors of failed medical management","volume":"170","author":"Marshall A","year":"2025","unstructured":"Marshall A, Wimsett J, Handforth C, Unsworth L, Wilson J, Van Der Merwe AM, Oyston C. The tubo-ovarian abscess study (TOAST): a single-center retrospective review of predictors of failed medical management. Int J Gynaecol Obstet. 2025, 170:927-35. 10.1002\/ijgo.70100","journal-title":"Int J Gynaecol Obstet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5603\/gpl.96824","article-title":"Which treatment should we choose for tubo-ovarian abscesses? Results of an 8-year clinical training in a tertiary center","volume":"95","author":"Bestel A","year":"2024","unstructured":"Bestel A, G\u00fcnkaya OS, Ald\u0131kactioglu Talmac M, et al.. Which treatment should we choose for tubo-ovarian abscesses? Results of an 8-year clinical training in a tertiary center. Ginekol Pol. 2024, 95:350-5. 10.5603\/gpl.96824","journal-title":"Ginekol Pol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06743-6","article-title":"Endometriosis is a risk factor for recurrent pelvic inflammatory disease after tubo-ovarian abscess surgery","volume":"307","author":"Zografou Themeli M","year":"2023","unstructured":"Zografou Themeli M, Nirgianakis K, Neumann S, Imboden S, Mueller MD. Endometriosis is a risk factor for recurrent pelvic inflammatory disease after tubo-ovarian abscess surgery. Arch Gynecol Obstet. 2023, 307:139-48. 10.1007\/s00404-022-06743-6","journal-title":"Arch Gynecol Obstet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408049-a-clinical-and-risk-factor-profile-of-patients-with-tubo-ovarian-abscesses-a-retrospective-study-from-two-district-hospitals-in-the-united-kingdom","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:52:18Z","timestamp":1757483538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408049-a-clinical-and-risk-factor-profile-of-patients-with-tubo-ovarian-abscesses-a-retrospective-study-from-two-district-hospitals-in-the-united-kingdom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.91947","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}